Alexander Dew

Diagnostic performance of 18F‐FDG‐PET/CT compared to standard skeletal survey for detecting bone destruction in smouldering multiple myeloma: time to move forward

P. Choyke, E. Mena, D. Kazandjian, 2020, British journal of haematology.

State of the science in smoldering myeloma: Should we be treating in the clinic?

D. Kazandjian, E. Hill, Alexander Dew, 2019, Seminars in oncology.

Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial.

S. Steinberg, B. Turkbey, R. Braylan, 2021, JAMA oncology.

Assessment of Discordance Among Smoldering Multiple Myeloma Risk Models.

M. Stetler-Stevenson, O. Landgren, C. Yuan, 2020, JAMA oncology.

Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.

W. Stock, K. van Besien, A. Artz, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence

R. Larson, W. Stock, A. Wickrema, 2009, Leukemia & lymphoma.

Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients

E. Papaemmanuil, I. Maric, O. Landgren, 2019, Blood Cancer Journal.

The changing role of high dose melphalan with stem cell rescue in the treatment of newly diagnosed multiple myeloma in the era of modern therapies-back to the future!

D. Kazandjian, E. Hill, Alexander Dew, 2020, Best practice & research. Clinical haematology.

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma

S. Steinberg, K. Camphausen, P. Choyke, 2021, The oncologist.

Stem-cell transplantation for sickle cell disease.

K. van Besien, Alexander Dew, 2010, The New England journal of medicine.

Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients

Neha Korde, Venkata Yellapantula, Elli Papaemmanuil, 2019, Blood Cancer Journal.